Scientist
AstraZeneca
Sarah joined AstraZeneca in 2022 and is a Senior Scientist within the Translational Medicine group as part of the AstraZeneca Vaccines and Immune Therapies unit. Sarah’s research focuses on the monitoring of phenotypic resistance of viral variants, including RSV, through clinical exploratory and surveillance endpoints. Sarah received her BS in Biological Sciences from University of Maryland, Baltimore County in 2020.